INTRODUCTION
I t has been established beyond doubt that infection with human papillomavirus (HPV) is a pre-requisite for developing squamous cervical cancer. 1 At least 30 types of HPV can infect the genital tract and they can be divided into two categories: low-risk (LR) types, which can cause benign epithelial lesions (e.g. genital warts), and high-risk (HR) types, which are associated with the development of cervical cancer (CC) and its precursor, high-grade cervical intraepithelial neoplasia (CIN). Genital warts are the most common of the sexually transmitted diseases with 79,678 new cases in 2004 in the UK, inflicting an enormous burden on sexual health clinics, with the cost per successful (treatment) outcome estimated at £221.81 for men and £211.07 for women. 2, 3 The most common consequence of genital HPV infection, however, is sub-clinical, with the infected individual experiencing no detrimental clinical effects. 4 Although development of cancer is an extremely unlikely consequence of genital HR-HPV infection, persistent infection with HR-HPV is necessary for its development. Currently, there is no cure for HR-HPV infection. However, cervical cytology-based screening programmes are designed to detect cervical cells that exhibit viral-mediated premalignant and malignant changes. The introduction of organized cervical screening has been an enormous success in the UK and is thought to have prevented an epidemic that would have killed around one in 65 British women born since 1950. 5 However, cytology screening is not infallible; the sensitivity of a single cytology test is thought to be 40-65%, with wide variety across different sites. 6 Thus, to compensate for this lack of sensitivity, screening is repeated many times (every 3-5 years in the UK) during a woman's life. Incorporation of HPV testing may enhance the sensitivity of cervical screening; the sensitivity of an HPV-positive result for the detection of significant disease is higher than that of a single cytology test and the negative predictive value (the number of people who test negative and who do not have the target condition) of an HPV-negative test is very high. 7 HPV testing has already been granted approval by the Food and Drug Administration in the USA for use in combination with cytology for screening in women over 30 years of age and for triage of low-grade smears. It is also being phased into clinical practice in several countries in mainland Europe. More locally, the results of the recent Department of Health UK HPV pilot studies showed that HPV testing for triage of low-grade abnormalities could be cost-effective. 8, 9 Should HPV testing be introduced in the UK, it is both ethical and necessary to ensure that the meaning of the test and the test results are communicated effectively to the patient and that available sources of information are accurate and suitable for discrete patient populations. Moreover, two prophylactic HPV vaccines (Cervarix and Gardasil, the latter of which is now licensed for use in Europe) have been shown to be efficacious and well tolerated and are expected to be made available in the near future. [10] [11] [12] These will offer protection against high risk HPV types 16 and 18 (which account for around 70% of cervical cancers) and Gardasil will, in addition, offer protection against types HPV 6 and 11, the types most commonly associated with genital warts. However, the vaccines' success will be contingent on high uptake within the population. It is therefore crucial that we gauge the public knowledge of HPV and issues that relate to it in order to identify any concerns that could have a bearing on uptake.
The focus of this report is to review those studies that have assessed the level of understanding of HPV (principally in its relation to cervical cancer) in patient populations and to assess key areas of importance for education. Articles were collated through PubMed searches on the terms: 'HPV education', 'HPV awareness' and 'Genital Warts Awareness' We will discuss the overall existing awareness of HPV in the population describing any demography-based differences before going on to define consistent knowledge gaps and areas of ambiguity and concern in relation to HPV as a virus, HPV testing and vaccination. We will then go on to examine the issues relating to imparting information on HPV particularly, the influence of different populations and clinical settings, the potential impact of online and media sources on public awareness and, lastly, the ways in which imparting information on HPV could be used for primary prevention of the disease.
THE SEXUALLY TRANSMISSIBLE ASPECT TO CERVICAL CANCER
The majority of genital HR-HPV infections are transmitted sexually. There have been reported cases of non-sexual transmission of genital HPV, and antibodies to genital HPV types have been found in pre-sexually active school children, although the detail of transmission pathways are unclear. 13, 14 It is significant that the sexual dimension of cervical cancer has been somewhat underplayed and sexually transmitted infection (STI) and cancer screening education initiatives have evolved ostensibly separately. This may be due to concerns that, by making the link between an STI and cervical abnormalities explicit, there will be a reduction in screening attendance by virtue of unpalatable connotations and stigmas frequently associated with an STI. 15, 16 To quote from McCaffery et al. 17 'The prospect of being tested for an STI as part of cervical screening was shocking to women unfamiliar with HPV'.
It is of note that the current National Health Service (NHS) cervical screening leaflet does not mention an STI specifically, but rather details behavioural risk factors (early onset of intercourse, multiple sexual partners) for its acquisition. 18 HPV is the most common STI in both the UK and the USA (in the latter, it is thought to account for 40% of all sexual infections but is rarely mentioned in general sexual-health literature and related websites). 19 Information on 'genital warts' is more readily available, but as discussed earlier, the LR-HPV types responsible for genital warts are different from those involved in cancer and this fundamentally important fact is perhaps insufficiently explained in the sources of information available to the public.
CURRENT LEVEL OF PUBLIC UNDERSTANDING OF HUMAN PAPILLOMAVIRUS Cross-study comparison
Various studies have assessed the level of the public's knowledge of and reactions to HPV, although some have focused on HPV in relation to genital warts rather than HPV and cervical cancer. Results obtained from the former may not be generalizable to the latter. Studies have differed with regard to data collection strategies; scoring a series of multiple choice questions, conducting open-ended questionnaires and use of focus groups. In addition, several studies have been non-population based.
Overall awareness of human papillomavirus
Inherent limitations notwithstanding, general trends have emerged with one main resounding consensus: knowledge of HPV in any context including as a causal agent in cervical cancer is very low. A study designed to assess public understanding of risk factors for cervical cancer in a representative British population sample revealed that only 14% were aware of a link with a sexually transmitted agent and fewer than 1% could actually name HPV. 16 At face value, this would appear to be at odds with the findings of Philips et al., 20 who reported that around 30% of women had 'heard of HPV', a figure consistent with the findings of Pitts and Clarke. 21 However, recognition of a term does not necessarily imply an ability to understand its implications or to be able to summon it without prompt in the correct context, and this contention is consistent with the findings of an Australian study. 22 
Awareness of risk factors associated with cervical cancer
Although the majority of the population are unlikely to recognize that acquisition of a specific STI is a risk factor for cancer, a much larger proportion do recognize 'some kind of' sexual aetiology to cervical cancer. This finding was evidenced in a UK survey of both men and women, which revealed that 67% of women and 51% of men recognized having several sexual partners (as opposed to practising monogamy) as a risk factor for cervical cancer. 23 The authors reported that those who, correctly, described multiple sexual partners as a risk factor may have rationalized it in terms of increased physical trauma to the cervix brought about by sex; this finding was also reported previously.
Awareness of human papillomavirus in relation to other sexually transmitted infections
Overall ignorance of HPV is common even in 'educated' populations especially when compared with other STIs. Yacobi et al. 24 assessed the level of knowledge relating to seven STIs, namely HPV, human immunodeficiency virus (HIV), Chlamydia trachomatis, Neisseria gonorrhoeae, herpes simplex virus, hepatitis B virus and Treponema pallidum, in a US university student population and found that HPV was significantly the least known and was the agent about which they had received the least education.
There also exists a confusion of HPV with other viruses beginning with the letter 'H', such as herpes simplex virus (HSV), HIV and the hepatitis viruses (HBC, HCV, etc.), and this phenomenon has been reported in both student, minority and representative population samples. 25 
Sociodemographic and behavioural differences relating to knowledge of human papillomavirus
Gender It is notable that few studies have assessed men's level of HPV knowledge related to cancer. Men are clearly not at risk of cervical cancer, but are genital carriers of HR-HPV and may be affected by the consequences of abnormal smears and cervical cancer by association. They may also be targeted in the future for prophylactic HPV vaccination strategies. It has also been suggested that women whose male partners have had multiple sexual partners in the past and/or have visited prostitutes are more likely to acquire HPV. 26 Moreover, men would benefit from education on HPV in other ways beyond its relation to cervical cancer -HPV infection has an aetiological role in anal cancer, screening for which works on the same principle of detection of pre-cancers through cytology (albeit that it is performed in groups considered at higher risk of this neoplasm). In addition, HPV is associated with approximately 45% penile carcinomas and men are also clearly at risk of acquiring genital warts, so can suffer the consequences of HPV-mediated disease directly and/or indirectly. 27 There is evidence to suggest that, compared with men, women are more likely to have heard of sexual behaviour risk factors (including acquisition of an STI), in relation to cervical cancer. 16, 28 This is consistent with earlier work by Fowler, 29 who found that women tend to be more interested in and knowledgeable about health issues than men and are more likely to respond to survey research.
Age
With regard to age, awareness of sexual behaviour and STIrelated risk factors for cervical cancer is lowest in those aged under 25 years, who are in fact the most likely to acquire HPV. 30 In a UK-based study of 1937 men and women, it was the 55-64 year olds who were most likely to be aware that sexual activity and multiple partners were risk factors for cervical cancer, while those aged 45-54 years were most likely to recognize that early onset of intercourse was a risk factor. The increased likelihood of older women either having had abnormal smears or coming into contact with someone who has, may account for this increased knowledge. It could be the case that the age-contingent differences observed are a result of cohort effects, with the type and emphasis of educational messages relating to cervical cancer prevention, changing as a result of organized screening. It was also interesting that the effects of gender, age and education on overall awareness of risk factors were largely independent of each other. 16 
Ethnicity
As would be expected, the level of knowledge of risk factors varies between ethnic groups. Mays et al. 31 found that in a study of minority women, only 30% could identify that cervical cytology screening was performed to detect cellular changes suggestive of pre-cancer. An extension of this logic is that the likelihood of awareness of an STI/HPV link with cancer in such a group would be negligible. This was also emphasized by McCaffery et al., 17 who assessed attitudes towards HPV testing among Indian, Pakistani, African Caribbean and white British women. They found that knowledge of the cervical screening rationale could not be taken for granted, particularly in the Asian women, a proportion of whom considered cervical cancer and related risk factors to be an issue of concern for western women only.
Additional factors -affect of smoking, abnormal smear results and level of education
One issue of concern is that HPV-positive women are at an increased risk of developing related cervical disease if they smoke, and that smokers are less informed, in general, about risk factors associated with cervical cancer. [32] [33] [34] This could therefore be an important group to target with respect to educational messages.
Perhaps unsurprisingly, women who have had abnormal smears in the past are more likely to have a knowledge of HPV, presumably as a consequence of increased motivation to acquire more information. 21 More generally, awareness of the link between an STI and cervical cancer has been found to increase with increasing amount of formal education. 30 However (with the exception of early age of first intercourse), knowledge of 'other' sexual behaviour risk factors has been found to be independent of educational level, and in one study, more educated respondents were more likely to mention incorrect risk factors. 16 WHAT DO THE POPULATION WANT TO KNOW REGARDING HUMAN PAPILLOMAVIRUS, WHAT SHOULD THEY KNOW, AND HOW SHOULD WE TELL THEM? Common knowledge gaps It is estimated that over 80% of sexually active women will have acquired HPV at some point in their life, with no associated adverse effects experienced by the majority. 35 However (as described earlier), knowledge of the term HPV is low in the community per se, so accurate knowledge of its prevalence will be less still. Communication of accurate prevalence figures is important so as to (1) assuage concern that an HPV-positive result indicates a significant disease state, (2) reduce feelings of shame and isolation commonly associated with STIs and (3) not jeopardize screening compliance in women who believe they are 'not at risk' of STIs. 36 Another source of confusion surrounds the level of protection (from transmission) conferred by condom use. This is potentially, in part, due to the somewhat conflicting evidence that exists on this topic. HPV infects the whole genital area and has been detected on the buttocks and perianal region, and a meta-analysis concluded that any protection provided by condoms is likely to be partial. 37 In addition, HPV is a very stable virus and transmissibility is severalfold higher than other sexually transmissible infections such as HSV2. Burchell et al. 38 also found that the partial protective effect of condoms could disappear over multiple sexual encounters. In a pooled analysis of the HPV prevalence data collated through the IARC studies, the authors found no significant association with HPV positivity and condom use. 39 However, it should be mentioned that, in the main, the studies that have assessed protection conferred by condom use have not been conducted using prospective cohorts in which sequential HPV testing has been performed in tandem with the acquisition of details on sexual behaviour. Recently, Winer et al. 40 performed such a longitudinal study in 82 female students who reported their first sexual intercourse with a male either during the study period or two weeks prior to its initiation. Fortnightly, women recorded information about their daily sexual behaviour into diaries, and they had a cervical exam and HPV test every four months. The results showed that women whose partners used condoms for all instances of vaginal intercourse during the previous eight months were 70% less likely to acquire a new infection than women whose partners used condoms o5% of the time. 40 Thus, considering this recent evidence and the fact that promotion of condom use for sexual health is clearly a worthwhile thing in general, it would not be disingenuous to state that condom use could prevent transmission of some HPV infections.
Another finding has been that women, especially young women, overestimate the incidence of cervical cancer. Incidence is currently estimated at 1-5 per 10,000 women per annum in the UK. One study found that 92.3% of 500 women in an English student population overestimated the incidence of cervical cancer, with 13.1% believing the incidence to be as high as one in 100. 20 There is also a lack of understanding on the high prevalence of HPV in the population, the sexual nature of its transmission and the frequent benign nature of its course. 41, 42 It is important to rectify such misconceptions, particularly if HPV testing is to be introduced in the future; women who test positive should have their result explained alongside the actual likelihood of disease so as to give the appropriate perspective. Indeed in a qualitative study of 74 women taken from the cervical screening population (who had received HPV testing), Waller et al. 43 found that the provision of accurate information relating to the ubiquity of HPV and the transient, sub-clinical course of most HPV infections gave reassurance.
Common queries regarding human papillomavirus and human papillomavirus testing in clinical management
Gilbert et al. 44 compiled a list of the 10 most frequently asked question about HPV (Box 1). This was performed under the auspices of the National HPV and Cervical Cancer Prevention Resource Centre (HPV RC), a US-based institution, which collected and analysed 4200 phone calls, 580 emails, 50 letters and 220 lecture questions. An expert panel of HPV researchers, clinicians and eminent public health educators produced consensus answers. 44 In a study of low-income and minority women, Anhang et al. 45 used focus groups to determine what such women found informative with regard to transmission of HPV and progression of HPV infection. In terms of transmission, women were interested in the fact that HPV was sexually transmitted, that it could occur through genital contact other than penetrative intercourse and that condoms were not wholly protective. In terms of progression, women wanted to know the typical duration of infection, the likelihood of viral clearance and of developing disease, and the screening and follow-up treatment that can prevent development of disease. 45 In a review article by Tristram ('HPV Information Needs'), 36 the author details 10 very pertinent 'key' messages to impart to women, when specifically talking about the link between cervical cancer. Largely, the emphasis was on high prevalence of infection, the importance of screening attendance, the fact that men are unlikely to be visibly affected and that most infections will not give rise to disease. In addition, another highly important statement in this list was 'Different types of HPV cause warts. Having genital warts does not lead to the development of cervical cancer'. 36 Both US-and UK-based studies have shown that there is a lack of understanding among women regarding the difference between low-risk and high-risk types, with women reporting that this should be made explicit. 45 Indeed, negative associations around the term 'wart' and 'wart virus' to describe HR-HPV have been reported. 22, 25 Use of these terms, which are common amongst health-care professionals, may therefore add to confusion and increase stigma and should be avoided if possible. Also, information which attempts to aggregate low-and high-risk types HPV can be misleading/misinterpreted. For example, a statement/heading such as 'Genital warts (human papillomavirus)' implies that the two terms are perhaps interchangeable with the extrapolation that genital warts can cause cancer (Model 1). A suggestion to avoid confusion would be to avoid the term 'genital wart virus' and rather mention HPV initially and then the terms low-risk and highrisk types (Model 2).
The benefits of the second model would be to improve overall public familiarity with the term HPV beyond the estimated current level of 30%, and to improve knowledge of the link between the HPVs associated with cancer without confusing them with the types that are involved with benign genital warts.
Acceptability of human papillomavirus vaccines
Recently, studies that have assessed public acceptability of the HPV vaccine have been published. Although these studies are a more indirect measure of overall/knowledge and awareness of HPV per se, they have highlighted some relevant issues. As the vaccine is likely to be recommended for 11-12 years olds, parental influence and guidance will be key, and their edification should be considered carefully. In a Manchester-based study of parental attitudes towards HPV vaccines, most were generally supportive although 15% remained opposed, with 6% of these steadfast in their opposition. 46 One might, therefore, speculate that the other 9%, who were not completely opposed, could be the most influenced/affected in their decision-making by an educational intervention from a reliable source, although it should be said that this particular study had just a 22% response rate. In a similar study in the USA, the authors concluded that unfamiliarity with HPV was influential in the lack of acceptability of a vaccine targeted against it. 47 Interestingly however, a more recent study designed to identify factors associated with parental acceptability of an HPV vaccine showed that 'attitudes and life experiences' were more influential for decision-making compared with provision of an HPV information sheet. 48 For an elegant review on the psychosocial aspects of vaccine acceptability, the reader should refer to a recent work by Zimet et al. 49
Imparting information --influence of different populations and settings
Women's ability to process and rationalize information pertaining to HPV and HPV testing will be influenced by the environment in which they receive it. In a US study of women attending colposcopy, 15% described themselves as Model 1 Genital warts -caused by HPV-can be linked with cancer Model 2 Genital HPV infection (with): -low-risk HPV types-most come to nothing but they can be linked with genital warts; -high-risk HPV types-most come to nothing but they can be linked with cancer 'extremely anxious', and individuals in a highly agitated state are less likely to assimilate information if encountering it for the first time. 50, 51 Le et al. 50 assessed knowledge and attitudes towards HPV testing among women attending colposcopy with low-grade smears. After a clinic worker explained the rationale of HPV testing, women were asked whether they wanted to be monitored with regular colposcopy every six months, or if they would prefer being tested for HPV to reduce the number of such colposcopy visits. In general, women considered test accuracy to be the most important factor in decision-making compared with cost and discomfort, and expressed a desire to receive information relating to this. The authors also found that women who had undergone previous treatment were more likely to accept HPV testing.
Increased media coverage and advertising of HPV testing could also lead to patient enquiries for information and potentially for the test. Certainly, primary care workers will play a pivotal role in imparting information and advice to the public if HPV testing and/or vaccination is to be introduced. 21 , 47 Holcomb et al. 52 found the two most favoured ways to receive information on HPV at a university health service were through pamphlets (61.4%) and healthcare workers (46.2%); other, less popular methods were health education class (22.8%), the internet (22.4%), and friends and family (13%). In addition, the vast majority (86.2%) believed that the most appropriate time to receive this information would be before becoming sexually active. 52 The first study to assess HPV knowledge among women in a primary health-care setting in the UK found that of the 316/1032 women who had heard of HPV, the sources of information were: the media (38.3%), general practitioner (GP) (18.7%), friend or family member (13.9%), internet (2.2%) or 'other' (23.4%). 30 Certainly, patients may have a number of questions and anxieties regarding the relatively complex set of choices brought about by having an HPV test. To date, however, there have been few studies that have assessed the level of HPV knowledge in primary health-care workers. Whitney et al. 53 proposed a 'shared decision-making' model (between patient and health-care worker) as the most appropriate for clinical situations where there is a 'diagnostic intervention of low-risk and a decision involving two or more acceptable choices'. Certainly, other sexual health promotion studies have found that, although leaflets are an extremely important first step, they are in themselves insufficient to encourage health behaviour change. 54 Resource constraints within primary care facilities will affect the practicality of providing extended consultation sessions with the GP. Thus, other health-care workers within the practice will play a significant role in communicating information relating to HPV and associated screening options to patients.
Unsurprisingly, religious and cultural beliefs also influence attitudes to HPV testing. Focus group research has revealed that women have expressed worry, shock, surprise and fear on learning that cervical cancer is linked with acquisition of an STI. Such reactions have been particularly marked in Indian and Pakistani populations, where there is a significant emphasis on monogamy and pre-marital sex is prohibited by Sharia law. 17 The Indian and Pakistani communities also placed a greater emphasis on mistrust and relationship difficulties concerning fidelity and suggested that highlighting the STI link in connection with cervical screening might place those attending for screening at risk of accusations of inappropriate behaviour from other members of their community. Box, 55 in a study of black and minority ethnic women, suggested that community health advocates could be employed to convey information regarding screening in a manner sensitive to a particular cultural belief system.
Irrespective of ethnicity, a finding of several studies is that women deemed existing information about HPV to be scanty and that the public response to the adoption of HPV testing will be largely determined by the effectiveness and the lucidity of information about the virus. On the whole, women were pleased to accept information regarding HPV and studies have shown the positive effect of improving knowledge of HPV after a brief educational intervention. 56, 57 However, the speculative attitudes of women regarding HPV and potential HPV testing may not reflect the attitudes of women who have actually received HPV-positive results. There is some contradiction in the literature with regard to this. Reed et al. 58 found that women experienced negligible negative psychosexual outcomes after being told they were HPV positive. However, a component study of the English HPV pilot studies (designed to evaluate the clinical, financial and psychological consequences of using HPV testing to manage women with low-grade smears) 59 showed that women who were told they were HPV positive exhibited considerably more anxiety than those who were untested. In addition, those who were told they were HPV negative were no more reassured than those who were untested. The authors supported the case for providing women with more accurate information in the future regarding the meaning of the HPV test. In HPV positive women, not knowing what the result meant was associated with higher anxiety. 60 Appropriate timing of this provision may be key as, in a follow-up paper to this study, Maissi et al. 61 found that the distress observed in women immediately after being informed of an HPV-positive result had largely dissipated at six months. Again, with respect to the psychological impact of HPV testing in a primary screening situation, a recent excellent study by McCaffery et al. 62 found that women's reactions were affected by their relationship status and their particular social and cultural conventions regarding sex and sexual relationships. Again, the authors argued strongly that the introduction of HPV testing would have to be partnered with organized, extensive health education of both the public and health-care workers.
Online sources and media coverage of human papillomavirus
Much information on HPV and HPV-associated disease is available on the internet. Some sites are devoted to HPV and some contain an HPV component, such as those for cervical screening, cervical cancer and STI (resulting in significant contextualization therein). Certain problems are associated with internet sources for health education such as the varying quality of the information offered and the unsolicited nature of some of the sites. In addition, the author of this article entered the term 'HPV' into the search engine Google on 1 May 2006 and received 8,430,000 hits; the potential for information overload for both patients and health-care workers is significant, especially as the latter tend to work on a 'need to know' basis. A study of UK websites containing HPV information as performed by the Wales College of Medicine concluded that six web sources would be the most appropriate for UK population, although it was not clear on what criteria the authors judged 'appropriateness'. 36 There has been a recent increase in media coverage of HPV, largely relating to the results of the prophylactic HPV ................ vaccine trials. 63 Prior to this recent exposure, Anhang et al. 64 conducted a study on News Media Coverage of HPV in the US, which comprised a content analysis of 111 news articles in top circulation papers or television programmes between 1995 and 2002. The main findings were that: there were substantial differences in the types of HPV information presented in stories pitched around STIs and stories focusing on a novel test for screening; several stories did not include basic information for which women have expressed a desire; facts and figures on HPV were often not contextualized and the majority did not make clear the delineation between HPV types associated with genital warts and those associated with cancer. It would be interesting to perform a similar systematic content analysis in the light of the recent media attention.
Primary prevention
What realistic messages can be communicated to the public regarding prevention of HPV? Delay of first intercourse and abstinence from sex would reduce the likelihood of acquiring HPV, but are obviously going to be unattractive and perhaps too moralistic for the majority. Waller et al. 65 discussed the interesting concept of focusing on trying to reduce the risk of HPV persistence (rather than infection) by making the link between smoking and cervical cancer explicit and by emphasizing the importance of attending regularly for smears. Lifetime number of partners is positively associated with HPV positivity, and was found to be more so than age at first intercourse in a recent metaanalysis on sexual behaviour and HPV prevalence. 39 Nonjudgemental communication of this fact which is, after all, a risk factor for a number of STIs would mean the public were at least informed with respect to another potential consequence of their sexual choices. This point could be communicated if HPV was to be incorporated within general sexual health education initiatives.
CONCLUSIONS
It would appear that there is scant public knowledge about HPV, especially, with regard to its link with abnormal smears and cervical cancer. There is also confusion regarding the HPV types associated with genital warts and those associated with cancer. Comprehensive educational pamphlets will be of importance in improving public awareness of HPV, and emphasis on prevention of HPV persistence, in addition to acquisition, may be suitable for patient populations. Box 2 details the main 'take home' messages as emphasized by this article. However, one of the main problems related to imparting HPV information is that the virus is highly prevalent, the majority of infections take a benign course and there is no direct cure for HPV. Therefore, people may be worried unnecessarily about two recognizably emotive issues (STIs and cancer) and we must be mindful of one of the central dogmas of health care, which is to 'at least do no harm'. 66 Thus, informed dissemination of appropriate information will be as important as the composition of the information materials themselves. Provision of HPV information should be tailored with discrete populations in mind in terms of demographics (e.g. sex, ethnicity) and the clinical situation in which it is imparted (e.g. at a routine screening visit, at a colposcopy clinic, pre-vaccination). How the media handles the information will be very important, and health-care professionals will clearly play a fundamental role in acting as a resource for enquiry and ensuring information is communicated effectively.
